CDKN2A and lung neoplasm: Spatial heterogeneity analysis of p16Ink4A expression in neuroendocrine and non-neuroendocrine tumors, revealed that p16Ink4A immunoreactivity is homogeneous across different areas of lung tumors, with the same recurring pattern of expression.